Latest News on PowerShares Dynamic Retail (PMR) ETF

  • Abercrombie & Fitch is Oversold [June 24 2016 01:26 PM]
  • Abercrombie & Fitch is Oversold   Nasdaq - 15 hours ago The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks , according to a proprietary formula designed to identify those stocks that combine two important characteristics - strong fundamentals and a ... Read more about this PowerShares Dynamic Retail (PMR) news
  • Mid-Day ETF Update: ETFs, Stocks in the Red as Markets Grapple with Brexit ... [June 24 2016 10:37 AM]
  • Mid-Day ETF Update: ETFs, Stocks in the Red as Markets Grapple with Brexit ...   Nasdaq - 18 hours ago Consumer Discretionary Select Sector SPDR (XLY) and retail funds SPDR S&P Retail (XRT), PowerShares Dynamic Retail (PMR) and Market Vectors Retail ETF (RTH) were lower. Sonic (SONC) was down 9.7% after disappointing Q3 same-store sales. Read more about this PowerShares Dynamic Retail (PMR) news


  • Will ConAgra Foods' Stock Gain from Its Fiscal 4Q16 Results? [June 24 2016 06:40 AM]
  • Will ConAgra Foods' Stock Gain from Its Fiscal 4Q16 Results?   Market Realist - 22 hours ago ... million pounds to its annual processing capacity. ConAgra is part of the PowerShares Dynamic Food and Beverage ETF (PBJ). .... This segment sells branded food items worldwide through retail channels. The next largest share comes from the Commercial ... Read more about this PowerShares Dynamic Retail (PMR) news


  • ETF Preview: ETFs, Futures Modestly Higher Ahead of Yellen Testimony Before ... [June 22 2016 06:30 AM]
  • ETF Preview: ETFs, Futures Modestly Higher Ahead of Yellen Testimony Before ...   Nasdaq - Jun 22, 2016 Consumer Discretionary SPDR (XLY) and retail funds SPDR S&P Retail (XRT), PowerShares Dynamic Retail (PMR) and Market Vectors Retail ETF (RTH) were flat. Tesla Motors (TSLA) was down 11% after the company disclosed that it had made an offer to ... ETF Preview: ETFs, Futures Poin... Read more about this PowerShares Dynamic Retail (PMR) news
  • PharmaMar Announces the Start of a Pivotal Study With plitidepsin in angioimmunoblastic T-cell lymphoma [June 14 2016 06:00 AM]
  • [PR Newswire] - PharmaMar (PHM) today announced the start of a multicenter, prospective, pivotal study to analyze the efficacy of the antitumoral compound of marine origin, plitidepsin in patients with relapsed and refractory angioimmunoblastic T-cell lymphoma. The primary objective is to analyze the efficacy of plitidepsin in terms of overall response rate, to be evaluated by an independent commi... Read more about this PowerShares Dynamic Retail (PMR) news

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center